The U.S. Medicare program's decision to tightly limit coverage for the first drug meant to slow the course of Alzheimer's disease has raised the stakes for companies trying to make the next one.
Apr 11, 2022
0
2
Scientists have provided the strongest evidence yet that a protein that enables us to detect the sensation of cold may also be responsible for migraines. The findings appear in the journal Pain.
Apr 11, 2022
0
122
A single dose of a nasal spray invented at the Norwegian University of Science and Technology (NTNU) restored breathing within ten minutes for 80% of overdose patients. More than 300 ambulance personnel in Trondheim and Oslo ...
Apr 7, 2022
0
25
The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the National Trends in Prescription ...
Apr 6, 2022
0
15
Almost half of the U.S. adult population has high blood pressure—or hypertension—and about 20% of these patients have treatment-resistant hypertension. The reason why some people are resistant to treatment has been a ...
Apr 5, 2022
0
2
A new animal study has provided important insights into how COVID-19 SARS-CoV-2—the virus responsible for COVID-19—can lead to long-term pain. The new findings also point to a potential therapy for COVID-related pain.
Apr 4, 2022
0
849
No one gave a second thought to the safety of dining out before the pandemic. Fast-forward to today, and it's normal to wonder whether there is a city, state or federal policy around whether you need a mask or proof of vaccination ...
Apr 4, 2022
0
24
Evidence of a relative to the bacteria that causes Lyme disease has been detected in human blood samples across New England, according to a new study led by researchers at the Yale School of Public Health.
Mar 24, 2022
1
231
Biogen Inc. on Wednesday published the full efficacy results from two late-stage studies of its Alzheimer's disease drug Aduhelm in a lesser-known medical journal, nine months after U.S. regulators cleared the treatment.
Mar 17, 2022
0
16
Research being conducted by Burnet scientists is helping to develop new drugs to combat malaria, which is becoming resistant to existing drugs.
Mar 10, 2022
1
33
